Purpose: To report the safety and efficacy of a new technique to prevent distal embolism during treatment of iliofemoral occlusions: reverse flow aspiration with proximal sheath blockage (ReFLAP). Method: Between October 2013 and December 2014, 90 patients (mean age 74 years; 66 men) were prospectively enrolled in a study to evaluate the ReFLAP technique during treatment of 110 occlusions in the iliac artery (72, 65%) or superficial femoral artery (SFA; 38, 35%). The mean occlusion lengths of iliac and SFA lesions were 79 and 179 mm, respectively. The concept of ReFLAP is to aspirate debris after balloon dilation using reverse flow through collaterals without antegrade flow. The main endpoints were the incidence of distal embolization, amputation, complications, and the ReFLAP capture rate, which was visually estimated during aspiration using 4 prespecified grades (0, none; 1, foamy debris; 2, small particles; 3, massive particles). Results: ReFLAP was successful in 105 (95.4%) of the 110 lesions attempted; the 5 failures were due to severe vessel tortuosity or calcification. The incidences of distal embolization and amputation were both 0. Minor complications unrelated to ReFLAP were observed in 8 patients. The ReFLAP procedure aspirated debris in 57 (54%) of the 105 lesions. Aspirated material, including marked clots (grades 2 and 3), was confirmed in 40 (38%) of the lesions. The distribution of aspiration grades was significantly different between iliac and SFA lesions (p=0.02). Conclusion: Our results suggest that the ReFLAP endovascular technique to prevent distal embolization during iliofemoral occlusive disease treatment is simple, safe, and effective.
Introduction
Endovascular therapy (EVT) is now widely performed, achieving good durability 1,2 even in more complicated lesions. 3 Complications associated with EVT for peripheral artery disease (PAD) include distal embolization, which can sometimes be serious. The incidence of distal embolization during iliac and femoropopliteal angioplasty/stenting has been reported to range from 2.3% to 4.5%. 4, 5 Several types of distal embolic protection devices, such as filters and balloon occlusion, have become available to prevent complications. [6] [7] [8] [9] EVT in long occlusive lesions has an increased potential for distal embolism, so it is important to manage it for better limb salvage. However, the use of distal embolic protection devices is problematic; the procedures are cumbersome, and the devices increase procedure cost.
A simple and inexpensive technique has been developed for distal embolization prevention based on a new concept of reverse flow aspiration with proximal sheath blockage (ReFLAP). A prospective investigation was conducted to determine the safety and efficacy of the technique.
Method

Study Design and Patient Population
A prospective, single-center, single-arm trial was designed to evaluate the safety and efficacy of the ReFLAP technique. Patients who met the following conditions were enrolled: age ≥40 years, chronic total occlusion (CTO) of the iliac artery and/or superficial femoral artery (SFA), Rutherford category 2-4 ischemia, an ankle-brachial index (ABI) ≤0.9, at least 1 vessel runoff, and life expectancy ≥1 year. Exclusion criteria included Rutherford category 1, 5, or 6; acute lower limb ischemia; serious congestive heart failure; coagulopathy; liver dysfunction; active gastrointestinal hemorrhage; peptic ulcer; intolerance to aspirin or ticlopidine; pregnant or possibility of becoming pregnant; and a life-threatening serious disease. The study was in accordance with the Declaration of Helsinki and was approved by the local ethics committee; written informed consent was obtained from every participant.
Between October 2013 and December 2014, 100 patients were screened for enrollment in this study; informed consent was not obtained from 6 patients and 4 did not ultimately meet the inclusion criteria, leaving 90 patients (mean age 74 years; 66 men) with 110 lesions in 101 limbs enrolled in the study. Characteristics of the patients and lesions are presented in Tables 1 and 2 , respectively. Oral antiplatelet agents were administered to all subjects; half the population was treated with statins. The majority of limbs (70/101, 69%) had symptoms of Rutherford category 3 ischemia. There were 72 (65%) iliac lesions and 38 (35%) SFA lesions; mean lesion lengths were 97 mm (occlusion length 79 mm) 187 mm (occlusion length 179 mm), respectively. Ten of the SFA lesions were in-stent occlusions.
ReFLAP Procedure
Step 1 ( Figure 1A ): A 6-or 7-F guiding sheath was inserted antegradely either from a brachial or contralateral femoral artery access site. After sheath insertion, a 5000-unit intra-arterial bolus of heparin was injected, with additional heparin given intravenously during the procedure to maintain the activated clotting time at >200 seconds. Conventional and digital subtraction angiography (DSA) of the entire target vessel was performed. After guidewire crossing of the CTO, the tip (10-15 mm) of a guiding sheath was inserted into the proximal end of the CTO. If that proved difficult, an anchor balloon technique was used to pull the sheath into the CTO. At this time, the absence of a pressure waveform from the sheath was confirmed.
Step 2 ( Figure 1B ): A balloon was inserted into the sheath and was inflated firmly all the way down to the distal end of the lesion; a single inflation with a long balloon (4.0-5.0 mm in diameter) was recommended. If pressure waveforms were observed from the sheath through collaterals (reverse flow), a syringe was connected to the sheath making sure the Y-connector was tightly closed to avoid air intrusion. Aspiration of 20 mL of material through the sheath was performed several times until visible debris disappeared. Compressing the groin area externally seemed to be effective for sufficient aspiration.
Step 3 ( Figure 1C ): Using a self-expanding stent long enough to cover the entire lesion and 1 to 2 mm larger than the reference vessel diameter, deployment was begun from the distal end of the lesion and stopped just before the sheath. The sheath was slowly withdrawn while deploying the rest of the stent. Antegrade circulation was restored at this point. Postdilation with a properly sized balloon was conducted. After the procedure, angiography (normal and DSA) was performed to estimate the presence of distal embolization. Intravascular ultrasound (IVUS) imaging was used in a subgroup of patients to assess wire passage (intraluminal or in the subintimal plane).
All patients were given dual antiplatelet therapy [DAPT; aspirin (100 mg/d) and clopidogrel (75 mg/d)] before the procedure. The DAPT was continued for at least 1 month for iliac lesions and at least 3 months for SFA lesions. Cilostazol (100 mg twice a day) was added at the operator's discretion. After the DAPT regimen, lifelong aspirin (100 mg/d) was continued.
Definitions and Outcome Measures
Distal embolization was defined as an angiographic defect with an abrupt "cutoff" in the distal target vessel. No-reflow was indicated by no distal antegrade vessel opacification by the contrast medium on angiography. Slow flow was regarded as delayed distal flow without complete reperfusion.
The capture rate of the ReFLAP technique was visually estimated during aspiration using 4 prespecified grades (0, none; 1, foamy debris; 2, small particles; 3, massive particles; Figure 2 ). The presence of distal embolization or noreflow or slow flow and the grading of aspirated debris were adjudicated by an independent reviewer.
The primary outcome measure was the incidence of distal embolization or no-reflow/slow flow. The secondary outcome measures were 30-day mortality, 30-day major (above-ankle)/minor amputation, the change in Rutherford category, complication (any reasons for prolonged hospital stay), and the ReFLAP capture rate based on the aspiration grade. 
Statistical Analysis
Continuous data are presented as the means ± standard deviation; categorical data are given as the counts (percentage). Continuous variables were examined using the unpaired t test; categorical variables were compared with the chi-square test. Statistical analysis was performed using JMP software (version 9; SAS Institute Inc, Cary, NC, USA).
Results
ReFLAP was successful in 105 (95.4%) of the 110 lesions attempted. The 5 failures (4 iliac, 1 SFA) in 3 patients (4 limbs) were due to severe tortuosity in 3 lesions and failure to insert the guide sheath due to severe calcification in 2. The 10 subjects with in-stent occlusion were treated with balloon angioplasty alone.
The outcomes for the 105 lesions (87 patients) in which ReFLAP was feasible are presented in Table 3 and a representative case is shown in Figure 3 . The postoperative incidence of distal embolization or no-reflow/slow flow was 0. No distal emboli were observed in the 10 subjects with instent occlusion as well, and debris containing thrombotic material was collected using the ReFLAP maneuver. Distal filter protection was used in 7 subjects, but no visible debris was detected in the filters.
All subjects completed 30-day follow-up. With respect to the secondary endpoints, 30-day mortality and 30-day major/minor amputations were both 0. While the postoperative symptom status as reflected by the Rutherford category improved in 81 (77%) of the 87 subjects in follow-up, 21 (20%) showed no change. No cyanosis was observed in the 3 subjects with deteriorating subjective symptoms after the procedure; 1 experienced pain at the puncture site and the other 2 had pain at the stenting sites. The ABI was improved in these subjects, and the symptoms improved within 1 month after the procedure. Complications were observed in 8 subjects, but these were not related to the ReFLAP procedure directly, and no serious complications were encountered.
The ReFLAP procedure aspirated debris in 57 (54%) of the 105 lesions. Aspirated material, including marked clots (grades 2 and 3), was confirmed in 40 (38%) of the lesions. The distribution of aspiration grade was significantly different between iliac and SFA lesions (p=0.02, Figure 4) . Although there was no significant difference in overall capture rate, the rate of grade 2 or more was significantly higher in iliac lesions than in SFA lesions (47% vs 24%, p=0.02; Figure 5A ). IVUS was performed in 72 lesions, which were analyzed to compare the capture rate according to intraluminal vs subintimal crossing. The capture rate of debris was significantly higher in the intraluminal crossing group (71% vs 23%, p=0.003; Figure 5B ).
Discussion
This study evaluated the safety and efficacy of a new preventive technique for distal embolism. The ReFLAP maneuver captured visible embolic materials in more than half of the procedures and did not lead to either distal embolism or no-reflow/slow-flow phenomena; furthermore, no severe complications were observed. This new technique is expected to be able to prevent distal embolism safely and simply without increasing procedure cost. However, ReFLAP has several provisions. First, during the ReFLAP maneuver, strong aspiration is not needed because the remaining plaque is covered with a stent. Predilation is performed to achieve a diameter suitable for passing a stent; consequently, the balloon diameter is relatively small (4-5 mm). ReFLAP does not collect the plaque and thrombi completely at the occluded site but rather the aspirated plaques (thrombi) that peel away and are suspended after predilation, retaining any remaining plaques within the stent. Aspirated materials are not abundant compared with atherectomy devices.
Second, it is necessary to definitively insert a sheath into the CTO proximal site to avoid antegrade flow. Recanalization of antegrade flow could cause distal embolism, so it is important after predilation to confirm no pressure gradient in the sheath and to perform the procedure using a Y-connector to prevent air contamination.
For iliac CTOs, primary stenting is generally performed and achieves good durability. 10, 11 On the other hand, there is no consensus about long SFA CTOs in which the entire lesion is covered with stents. 1, 12, 13 The efficacy of optimal balloon angioplasty, drug-coated balloon (DCB) angioplasty with/without atherectomy, 14, 15 spot stenting, 16 and covered stenting 17 with the concept of "leave nothing behind" or "less metal" should be examined.
Significant distal embolism is rare in subintimal angioplasty for iliac and femoropopliteal CTOs. 18, 19 Therefore, ReFLAP will likely have greater utility in an intraluminal approach and for in-stent occlusion to prevent distal embolism. ReFLAP performed in 10 subjects with SFA in-stent occlusion led to capture of grade 2 or higher embolic materials in all subjects, and no distal emboli were confirmed after balloon expansion.
With regard to CTO lesions with thrombotic occlusion, in addition to distal protection devices, mechanical thrombectomy 20, 21 and debulking devices 22, 23 have been effective. The application and efficacy of these devices should be considered relative to their respective costs.
Limitations
This study was conducted in a small number of patients, which precluded detailed analysis. To prove that ReFLAP has the same effect as common distal protection devices, it will be necessary to demonstrate noninferiority in a randomized trial.
This study was conducted by expert physicians with experience in EVT procedures and knowledge of ReFLAP. Therefore, the good outcomes in this study might not be reproducible in many facilities, and multicenter prospective studies should be conducted to support these findings.
In addition, patients with Rutherford category 5/6 ischemia were eliminated from this study for safety reasons. The possibility cannot be ruled out that subclinical distal emboli may develop after predilation. It will be necessary to evaluate whether ReFLAP exhibits the same safety and efficacy in patients with critical limb ischemia, poor runoff, and tissue loss. This technique also could be investigated in cases of suspected acute on chronic thrombotic events or in subacute occlusions within 3 months.
Furthermore, there are some technical limitations. Even after stenting, debris can be generated after postdilation, which this technique cannot prevent. The true incidence of distal embolization, including subclinical distal embolization, remains unclear as a filter was not used with every patient.
Conclusion
Our results suggest that the ReFLAP endovascular maneuver to prevent distal embolization during iliofemoral occlusive disease treatment is simple, safe, and effective.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
